A novel treatment regimen for BK Viremia

Transplantation

Volumn 97, Issue 11, 2014, Pages 1166-1171

  Zaman, Rumina A ^a   Ettenger, Robert B ^a   Cheam, Hay ^a   Malekzadeh, Mohammed H ^a   Tsai, Eileen W ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

BK nephropathy; Children; Kidney dysfunction

Indexed keywords

CALCINEURIN INHIBITOR; CIPROFLOXACIN; IMMUNOGLOBULIN G; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADOLESCENT; ANTIBODY MEDIATED REJECTION; ANTIVIRAL THERAPY; ARTICLE; BK VIREMIA; BK VIRUS; BK VIRUS INFECTION; COHORT ANALYSIS; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ADOLESCENT; BK VIRUS; CHILD; CIPROFLOXACIN; FEMALE; FLUOROQUINOLONES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KIDNEY TRANSPLANTATION; MALE; NUCLEIC ACID SYNTHESIS INHIBITORS; POLYOMAVIRUS INFECTIONS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS; VIREMIA;

EID: 84902142680     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000441825.72639.4f     Document Type: Article

References (34)

1. Acottt PD. Polyoma virus in pediatric renal transplantation. Pediatr Transplant 2006; 10: 856.
2. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirusassociated nephropathy in renal transplantation: Interisciplinary analyses and recommendations. Transplanation 2005; 79: 1277.
3. Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007; 22: 1243.
4. Smith JM, Dharnidkarka VR, Talley L, et al. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry. Clin J Am Soc Nephrol 2007; 2: 1037.
5. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115.
6. Stolt A, Sasnauskas K, Kosela P, et al. Seroepidemilogy of the human polyomaviruses. J Gen Virol 2003; 84: 1499.
7. Ali AM, Gibson IW, Birk P, et al. Pretransplant serologic testing to identify the risk of polyoma BK viremia in pediatric kidney transplant recipients. Pediatr Transplant 2011; 15: 827.
8. Smith JM, McDonald RA, Finn LS, et al. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004; 4: 2109.
9. Ginervi F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266.
10. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834.
11. Ramos E, Drachenberg CB, Wali R, et al. The decade of polyomavirus BK-Associated nephropathy: state of affairs. Transplantation 2009; 87: 621.
12. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
13. Puliyanda DP, Toyoda M, Traum AZ, et al. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant 2008; 12: 180.
14. Cannon RM, Brock G, Marvin MR, et al. Analysis of BK viral infection after alemtuzumab induction for renal transplant. Transpl Infect Dis 2012; 14: 374.
15. Materne C, Gerth J, Ott U, et al. Oscillation between BK virus nephropathy and rejection - the frustrating course of a living donor transplantation. Med Klin 2009; 104: 644.
16. Tanabe T, Shimizu T, Sai K, et al. BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report. Clin Transplant 2011; 25(Suppl. 23): 39.
17. Hymes LC, Warshaw BL. Polyomavirus BK in pediatric renal transplants. Evaluation of viremic paitents with and without BK associated nephritis. Pediatr Transplant 2006; 10: 920.
18. Anyaegbu EI, Almond PS, Milligan T, et al. Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients. Pediatr Transplant 2012; 16: E19.
19. Farasati NA, Shapiro R, Vats A, et al. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005; 79: 116.
20. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704.
21. Araya CE, Garin EH, Neiberger RE, et al. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients. Pediatr Transplant 2009; 14: 145.
22. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9: 205.
23. Ali SH, Charaker A, DeCaprio JA. Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. Antiviral Ther 2007; 12: 1.
24. Chandraker A, Ali S, Drachenberg CB. Use of fluroroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004; 4: 587.
25. Garbadi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol 2010; 5: 1298.
26. Meier P, Dautheville-Guibal S, Ronco PM, et al. Cidofovir-induced end-stage renal failure. Nephro Dial Transpl 2002; 17: 148.
27. Leung AYK, Chan MTL, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528.
28. Koukoulaki M, Apostolou T, Hadjiconstantinou V, et al. Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication. Transpl Infect Dis 2008; 10: 449.
29. Hardinger KL, Koch MJ, Bohl DJ, et al. BK virus and the impact of preemptive immunosuppression reduction: 5-year results. Am J Transplant 2010; 10: 407.
30. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615.
31. Menter T, Mayr M, Schaub S, et al. Pathology of resolving polyomavirusassociated nephropathy. Am J Transplant 2013; 13: 1474.
32. Nickeleit V, Hirsch H, Binet I Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080.
33. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
34. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-Term infants during the first year of life. J Pediatr 1984; 104: 849.